Journals / Bitlis Eren Üniversitesi Fen Bilimleri Dergisi / 2025 / Volume: 14 Issue: 4

Competitive Inhibition of Glutathione Reductase Activity by Cyclohexyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide and Benzyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide

Hasan Karadağ(Adıyaman Üniversitesi)0000-0001-5701-8445
Murat Genç(ADIYAMAN ÜNİVERSİTESİ)0000-0003-1224-4128
Pages
—
Publication Date
2025-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CHX and BNZ inhibited GR enzyme activity as competitively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this research, 0, 25, 50, 100, 200 and 400 mg/L (ppm) concentrations of 2-aminoimidazolines (cyclohexyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide (CHX) and benzyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide (BNZ)) were applied to baker's yeast (Saccharomyces cerevisiae) glutathione reductase (GR).
📊
Key Findings & Data:Since the inhibition constant (Ki) (43 ± 2 nM) and 50 % inhibition concentration (IC50) (947 mg/L =3.13×10-3 M) values of BNZ were found to be smaller than the Ki (59 ± 17 nM) and IC50 (1461 mg/L =4.95×10-3 M) values of CHX.
💡
Conclusion & Impact:CHX and BNZ inhibited GR enzyme activity as competitively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Benzyl-(4 · 5-dihydro-1H-imidazol-2-yl)amine hydroiodide · Cyclohexyl-(4

Abstract

In this research, 0, 25, 50, 100, 200 and 400 mg/L (ppm) concentrations of 2-aminoimidazolines (cyclohexyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide (CHX) and benzyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide (BNZ)) were applied to baker's yeast (Saccharomyces cerevisiae) glutathione reductase (GR). Since the inhibition constant (Ki) (43 ± 2 nM) and 50 % inhibition concentration (IC50) (947 mg/L =3.13×10-3 M) values of BNZ were found to be smaller than the Ki (59 ± 17 nM) and IC50 (1461 mg/L =4.95×10-3 M) values of CHX. At imidazoline concentrations of 400 mg/L, CHX reduced GR activity by 16.07 %, while BNZ reduced GR activity by 21.96 %. BNZ inhibited GR more than CHX. In addition, molecular docking results also support the experimental data. CHX and BNZ inhibited GR enzyme activity as competitively.

🔖

Cite This Article

Karadağ, H., Genç, M. (2025). Competitive Inhibition of Glutathione Reductase Activity by Cyclohexyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide and Benzyl-(4,5-dihydro-1H-imidazol-2-yl)amine hydroiodide. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi, Volume: 14 Issue: 4. https://doi.org/10.17798/bitlisfen.1740818

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. A. M. S. El-Sharief, A. M. Al-Amri, and S. Y. Al-Raqa, “Halogenated, alkylated and new types of imidazolidine, pyrrolidine, imidazotriazine and thienoimidazole derivatives with biological and antitumor activities,” J. Sulphur Chem., vol. 27, no. 3, pp. 245–263, 2006. https://doi.org/10.1080/17415990600631316
  2. C. Dardonville, P. Goya, I. Rozas, A. Alsasua, M. I. Martín, and M. J. Borrego, “New aromatic iminoimidazolidine derivatives as alpha1-adrenoceptor antagonists: a novel synthetic approach and pharmacological activity,” Bioorg. Med. Chem., vol. 8, no. 7, pp. 1567–1577, 2000.https://doi.org/10.1016/S0968-0896(00)00089-4
  3. A. R. Katritzky and B. V. Rogovoy, “Recent developments in guanylating agents,” Arkivoc, vol. 2005, no. 4, pp. 49–87, 2005. https://doi.org/10.3998/ark.5550190.0006.406
  4. A. Işık, U. Acar Çevik, B. N. Sağlık, and Y. Özkay, “Synthesis, characterization, and molecular docking study of some novel imidazole derivatives as potential antifungal agents,” J. Heterocycl. Chem., vol. 56, no. 1, pp. 142–152, 2019. https://doi.org/10.1002/jhet.3388
  5. G. Mariappan, R. Hazarika, F. Alam, R. Karki, U. Patangia, and S. Nath, “Synthesis and biological evaluation of 2-substituted benzimidazole derivatives,” Arab. J. Chem., vol. 8, no. 5, pp. 715–719, 2015. http://dx.doi.org/10.1016/j.arabjc.2011.11.008
  6. H. Majed and F. W. Askar, “Synthesis and biological evaluation of new Benzimidazole derivatives,” Al-Mustansiriyah J. Sci., vol. 29, no. 1, pp. 107–113, 2018. https://doi.org/10.23851/mjs.v29i1.127
  7. M. Farag, W. M. Abdel-Mageed, O. Basudan, and A. El-Gamal, “Persicaline, A new antioxidant sulphur-containing imidazoline alkaloid from Salvadora persica roots,” Molecules, vol. 23, no. 2, 2018. https://doi.org/10.3390/molecules23020483
  8. D. R. Bazanov et al., “2,4,5-Tris(alkoxyaryl)imidazoline derivatives as potent scaffold for novel p53-MDM2 interaction inhibitors: Design, synthesis, and biological evaluation,” Bioorg. Med. Chem. Lett., vol. 29, no. 16, pp. 2364–2368, 2019. https://doi.org/10.1016/j.bmcl.2019.06.007
  9. B. Halliwell and J. M. C. Gutteridge, Free radicals in biology and medicine, 3rd ed. London, England: Oxford University Press, 1999, pp. 143-144.
  10. M. Genc and S. Servi, “Microwave-induced synthesis of 2-aminoimidazolines under neat conditions,” Synth. Commun., vol. 39, no. 18, pp. 3263–3277, 2009. http://dx.doi.org/10.1080/00397910902739896
  11. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” J. Biol. Chem., vol. 193, no. 1, pp. 265–275, 1951. https://doi.org/10.1016/S0021-9258(19)52451-6
  12. I. Carlberg and B. Mannervik, “Purification and characterization of the flavoenzyme glutathione reductase from rat liver,” J. Biol. Chem., vol. 250, no. 14, pp. 5475–5480, 1975.
  13. H. Karadag, “Inhibition of glutathione reductase activity from baker’s yeast (Saccharomyces cerevisiae) by copper(II) oxide nanoparticles and copper(II) chloride,” Bull. Environ. Contam. Toxicol., vol. 106, no. 4, pp. 647–651, 2021. https://doi.org/10.1007/s00128-021-03136-4
  14. A. Öztürk Kesebi̇r, “Tiyazol Türevlerinin Glutatyon Redüktaz Üzerindeki İnhibitör Etkilerinin Belirlenmesi,” Afyon Kocatepe Univ. J. Sci. Eng., vol. 21, no. 6, pp. 1315–1323, 2021. https://doi.org/10.35414/akufemubid.1019128
  15. I. N. Korkmaz, “In vitro inhibition effects of 2-amino thiazole derivatives on lactoperoxidase enzyme activity,” Cumhur. Sci. J., vol. 43, no. 1, pp. 33–37, 2022. https://doi.org/10.17776/csj.1017247
  16. P. Ascenzi, M. Fasano, M. Marino, G. Venturini, and R. Federico, “Agmatine oxidation by copper amine oxidase: Biosynthesis and biochemical characterization of N-amidino-2-hydroxypyrrolidine,” Eur. J. Biochem., vol. 269, no. 3, pp. 884–892, 2002. https://doi.org/10.1046/j.0014-2956.2002.02718.x